Bailie and Mason's 2018 Dialysis of Drugs

Description

Bailie and Mason's 2018 Dialysis of Drugs is an authoritative clinical reference designed to guide healthcare professionals in optimizing medication therapy for patients undergoing dialysis. This extensively updated 2018 edition delivers critical pharmacokinetic and pharmacodynamic data, including drug clearance rates, dialyzability, dosing recommendations, and therapeutic considerations for various dialysis modalities such as hemodialysis and peritoneal dialysis.

Developed for nephrologists, clinical pharmacists, hospital practitioners, and renal care specialists, this indispensable guide supports evidence-based decision-making in patients with acute kidney injury (AKI) and end-stage renal disease (ESRD). Each monograph provides detailed information on drug properties, molecular weight, protein binding, volume of distribution, and dialysis removal characteristics to help clinicians make accurate dosage adjustments and minimize adverse effects.

Key Features:
Comprehensive drug monographs with dialysis dosing guidelines
Hemodialysis and peritoneal dialysis removal data
Updated pharmacokinetic parameters
Practical recommendations for safe medication management
Essential reference for renal pharmacotherapy and nephrology practice

Whether used in hospitals, dialysis centers, or academic settings, Bailie and Mason's 2018 Dialysis of Drugs remains a gold-standard reference for safe, effective drug dosing in dialysis patients.